Evidence map›Paper›PMID 30445918›Full record

ArticleBMC microbiology2018

Taxonomic classification for microbiome analysis, which correlates well with the metabolite milieu of the gut.

Yoshihisa Wakita, Yumi Shimomura, Yusuke Kitada, Hiroyuki Yamamoto, Yoshiaki Ohashi, Mitsuharu Matsumoto

Abstract read
In one paragraph

Article in BMC microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Microbiome changes associated with acute and chronic pancreatitis: A systematic review.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2021
    Pooled it
  3. Article
  4. Consequences ofMicroorganisms · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. The Gut Microbiome in Anxiety Disorders.Current psychiatry reports · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoshihisa WakitaFrontier Laboratories for Value Creation, Sapporo Holdings Ltd., Yaizu, Shizuoka, 425-0013, Japan.
Yumi ShimomuraDairy Science and Technology Institute, Kyodo Milk Industry Co. Ltd., Hinode-machi, Tokyo, 190-0182, Japan.
Yusuke KitadaDairy Science and Technology Institute, Kyodo Milk Industry Co. Ltd., Hinode-machi, Tokyo, 190-0182, Japan.
Hiroyuki YamamotoHuman Metabolome Technologies, Inc., Tsuruoka, Yamagata, 997-0052, Japan.
Yoshiaki OhashiHuman Metabolome Technologies, Inc., Tsuruoka, Yamagata, 997-0052, Japan.
Mitsuharu MatsumotoDairy Science and Technology Institute, Kyodo Milk Industry Co. Ltd., Hinode-machi, Tokyo, 190-0182, Japan. m-matumoto@meito.co.jp.ORCID 0000-0002-0378-3077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background16S rRNA gene amplicon sequencing analysis (16S amplicon sequencing) has provided considerable information regarding the ecology of the intestinal microbiome. Recently, metabolomics has been used for investigating the crosstalk between the intestinal microbiome and the host via metabolites. In the present study, we determined the accuracy with which 16S rRNA gene data at different classification levels correspond to the metabolome data for an in-depth understanding of the intestinal environment.

resultsOver 200 metabolites were identified using capillary electrophoresis and time-of-flight mass spectrometry (CE-TOFMS)-based metabolomics in the feces of antibiotic-treated and untreated mice. 16S amplicon sequencing, followed by principal component analysis (PCA) of the intestinal microbiome at each taxonomic rank, revealed differences between the antibiotic-treated and untreated groups in the first principal component in the family-, genus, and species-level analyses. These differences were similar to those observed in the PCA of the metabolome. Furthermore, a strong correlation between principal component (PC) scores of the metabolome and microbiome was observed in family-, genus-, and species-level analyses.

conclusionsLower taxonomic ranks such as family, genus, or species are preferable for 16S amplicon sequencing to investigate the correlation between the microbiome and metabolome. The correlation of PC scores between the microbiome and metabolome at lower taxonomic levels yield a simple method of integrating different "-omics" data, which provides insights regarding crosstalk between the intestinal microbiome and the host.

Indexed as

MetabolomeAnimalsBacteriaDNA, BacterialFecesIntestinal MucosaIntestinesMaleMass SpectrometryMetabolomicsMiceMice, Inbred C57BLPhylogenyPrincipal Component AnalysisRNA, Ribosomal, 16SDNA, BacterialRNA, Ribosomal, 16S16S amplicon sequencingGut microbiomeMetabolomePrincipal component analysisTaxonomy

Identifiers

PMID30445918
PMCPMC6240276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.